PMDA drug package insert
新レシカルボン坐剤
PMDA Prescription drug · 京都薬品工業株式会社 · package insert Sep 12, 2022
Key facts
| Brand names | 新レシカルボン坐剤 |
|---|---|
| Nonproprietary names | 炭酸水素ナトリウム・無水リン酸二水素ナトリウム |
| Companies | 製造販売元／京都薬品工業株式会社, 発売元／ゼリア新薬工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 便秘治療剤 |
| Therapeutic category codes | 872359 |
| YJ codes | 2359800J1035 |
| Approval numbers | 20400AMZ00323000 |
| Package insert edition | 第1版 |
| Package insert date | Sep 12, 2022 |
| PMDA document key | 230099_2359800J1035_1 |
| PMDA company code | 230099 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: